Eudaimonia Partners’s Starbucks SBUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$388K Buy
4,247
+1
+0% +$93 0.09% 166
2023
Q4
$408K Sell
4,246
-1,416
-25% -$138K 0.11% 157
2023
Q3
$517K Sell
5,662
-248
-4% -$24.3K 0.13% 167
2023
Q2
$585K Sell
5,910
-110
-2% -$11.4K 0.13% 162
2023
Q1
$627K Buy
6,020
+76
+1% +$7.91K 0.15% 151
2022
Q4
$590K Buy
5,944
+151
+3% +$14.3K 0.14% 158
2022
Q3
$488K Sell
5,793
-238
-4% -$20.2K 0.13% 166
2022
Q2
$461K Buy
6,031
+203
+3% +$15.6K 0.08% 228
2022
Q1
$530K Buy
+5,828
New +$550K 0.09% 225
2021
Q3
$795K Sell
7,209
-170
-2% -$19.9K 0.14% 173
2021
Q2
$825K Buy
7,379
+925
+14% +$105K 0.15% 160
2021
Q1
$705K Sell
6,454
-622
-9% -$65.3K 0.15% 160
2020
Q4
$757K Buy
7,076
+314
+5% +$30K 0.17% 139
2020
Q3
$581K Buy
6,762
+67
+1% +$5.34K 0.15% 149
2020
Q2
$493K Sell
6,695
-785
-10% -$59K 0.19% 127
2020
Q1
$492K Buy
7,480
+2,262
+43% +$183K 0.22% 114
2019
Q4
$459K Buy
+5,218
New +$445K 0.18% 133

Other funds holding SBUX

Eudaimonia Partners's SBUX Position: Q1 2024 in Review

Eudaimonia Partners increased its Starbucks (SBUX) stake by 0.02% in Q1 2024, buying an estimated $93 and bringing the position to 4,247 shares worth $388K. The position accounts for 0.09% of the portfolio, ranked #166.

Eudaimonia Partners first reported a position in SBUX in Q4 2019 and has held it in 17 quarters since. The position peaked at $825K in Q2 2021. 2,441 funds tracked by Wall St. Rank hold SBUX as of Q1 2024.

  • Eudaimonia Partners held 4,247 shares of Starbucks worth $388K as of Q1 2024.
  • Eudaimonia Partners bought 1 Starbucks share in Q1 2024, an estimated $93.
  • Starbucks made up 0.09% of Eudaimonia Partners's portfolio in Q1 2024, its #166 holding.
  • Eudaimonia Partners first reported a position in Starbucks in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's Starbucks position peaked at $825K in Q2 2021.
  • 2,441 funds tracked by Wall St. Rank held Starbucks as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.